...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Equity offering
Reply New Message
Back To Forum List View
Equity offering
5
masila
Jun 04, 2018 04:39PM
Re: Equity offering
3
Hartland
Jun 04, 2018 04:51PM

I've asked the company a couple of times since the first announcement of a 10MM share offering whether the investment was to be in ZCC or ZEL.  Each time the reply has been non-comittal.

4 Recommendations
Re: Equity offering
4
tada
Jun 04, 2018 07:05PM
Re: Equity offering
5
Polar one
Jun 06, 2018 01:49PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply